Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transenterix Inc (NYSE MKT LLC:TRXC)

1.34
Delayed Data
As of Jul 22
 +0.01 / +0.75%
Today’s Change
1.03
Today|||52-Week Range
6.10
-45.97%
Year-to-Date
Better Buy: TransEnterix, Inc. vs. Medtronic
Jul 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.33
Today’s open1.30
Day’s range1.27 - 1.38
Volume396,251
Average volume (3 months)1,869,454
Market cap$153.8M
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)+7.81%
Earnings growth (this year)+15.82%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
ATRSAntares Pharma Inc+0.01+1.00%
TTOOT2 Biosystems Inc-0.20-3.55%
GIEndoChoice Holdings ...+0.20+4.04%
OCULOcular Therapeutix I...+0.02+0.39%
Data as of 07/22/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
Todd M. Pope
Vice President-
Operations
Larry Pope
Corporate headquarters
Morrisville, North Carolina

Forecasts

Partner Offers

Search for Jobs